Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Jornal de Pediatria

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2009.05.005PMID 19616787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Complications in Adult Patients With Cystic Fibrosis

  2008cited by this paper
• Evaluation of the forced oscillation technique for clinical assessment of young children with cystic fibrosis

  2008cited by this paper
• Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.

  2007cited by this paper
• Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease.

  2007cited by this paper
• Imaging and clinical trials in cystic fibrosis.

  2007cited by this paper
• Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis (CF) Patients: Comparison to Thin-Section CT and Chest X-ray

  2007cited by this paper
• Imaging of the chest in cystic fibrosis.

  2007cited by this paper
• Reproducibility of a Scoring System for Computed Tomography Scanning in Cystic Fibrosis

  2006cited by this paper
• Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis

  2006cited by this paper
• Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis

  2005cited by this paper
• High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis.

  2005cited by this paper
• Changes in airway dimensions on computed tomography scans of children with cystic fibrosis.

  2005cited by this paper
• Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation

  2005cited by this paper
• Diagnosis of cystic fibrosis after newborn screening: The Australasian experience—twenty years and five million babies later: A consensus statement from the Australasian paediatric respiratory group

  2005cited by this paper
• High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.

  2004cited by this paper
• Structural airway abnormalities in infants and young children with cystic fibrosis.

  2004cited by this paper
• Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis

  2004cited by this paper
• Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements.

  2004cited by this paper
• Quantitative air‐trapping analysis in children with mild cystic fibrosis lung disease

  2004cited by this paper
• Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs.

  2003cited by this paper
• Cost of delayed childbearing

  2002cited by this paper
• Cystic fibrosis: CT assessment of lung involvement in children and adults.

  1999cited by this paper
• Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis

  1996cited by this paper
• Ultrafast computerized tomography of the chest in cystic fibrosis: A new scoring system

  1991cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper

• Short-term monitoring of CFTR modulator therapy in adults and children with cystic fibrosis using low and ultra-low-dose lung CT.

  2026cites this paper
• The single-cell transcriptional landscape of the pediatric cystic fibrosis lung from minimally invasive respiratory specimens

  2026cites this paper
• Feasibility and Utility of Multiple Breath Washout Measured Scond and Sacin in Preschool Children With Cystic Fibrosis

  2025cites this paper
• Cystic Fibrosis Newborn Screening.

  2025cites this paper
• Predicting Pulmonary Exacerbations in Cystic Fibrosis Using Inflammation-Based Scoring Systems

  2025cites this paper
• Protease-activated receptor 1 in the pathogenesis of cystic fibrosis

  2025cites this paper
• Ultralow dose computed tomography as an alternative to conventional chest radiography for the evaluation of disease severity in paediatric cystic fibrosis

  2025cites this paper
• A New Simple to Use Chest CT Scoring System: Validation Study

  2025cites this paper
• Pulmonary endpoints in clinical trials for children with cystic fibrosis under two years of age.

  2025cites this paper
• Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation

  2024cites this paper
• The effect of respiratory muscle training on children and adolescents with cystic fibrosis: a systematic review and meta-analysis

  2024cites this paper
• Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians.

  2024cites this paper
• Point of care lung ultrasound in preschool children with cystic fibrosis: a case-controlled, prospective, pilot study

  2024cites this paper
• Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study.

  2024cites this paper
• Impact of elexacaftor-tezacaftor-ivacaftor in lung transplantation for cystic fibrosis in the United States

  2024cites this paper
• Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6‐11 years with cystic fibrosis in a real‐world setting

  2024cites this paper
• Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF.

  2024cites this paper
• Cystic Fibrosis: A Review.

  2023cites this paper
• Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy

  2023cites this paper
• TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease

  2023cites this paper
• CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.

  2023cites this paper
• Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial

  2023cites this paper
• Comparative sensitivity of Early Cystic Fibrosis Lung Disease detection tools in school aged children

  2023cites this paper
• Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.

  2023cites this paper
• The effect of CFTR modulators on structural lung disease in cystic fibrosis

  2023cites this paper
• Impact of intrinsic and extrinsic risk factors on early‐onset lung disease in cystic fibrosis

  2023cites this paper
• Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

  2023cites this paper
• Global research status and trends of bronchiectasis in children from 2003 to 2022: A 20-year bibliometric analysis

  2023cites this paper
• Data Resource Profile: Melbourne Children’s LifeCourse initiative (LifeCourse)

  2022cites this paper
• The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.

  2022cites this paper
• Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis.

  2022cites this paper
• Mucus-targeting therapies of defective mucus clearance for cystic fibrosis: A short review.

  2022cites this paper
• A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant.

  2022cites this paper
• Factors in childhood associated with lung function decline to adolescence in cystic fibrosis.

  2022cites this paper
• The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.

  2022cites this paper
• Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases

  2022cites this paper
• Cystic fibrosis in the 21st century: what every radiologist should know.

  2022cites this paper
• The Small-Molecule Language of Dynamic Microbial Interactions.

  2022cites this paper
• Defining and identifying early‐onset lung disease in cystic fibrosis with cumulative clinical characteristics

  2022cites this paper
• Association Between Evolution of Mucus Plugging, Parenchymal Alterations and Air Trapping on Computed Tomography and Risk of Exacerbations in Adults With Cystic Fibrosis.

  2021cites this paper
• Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

  2021cites this paper
• The use of e-cigarettes and its risk of respiratory diseases

  2021cites this paper
• Hypertonic saline in the treatment of patients with cystic fibrosis in Russian Federation

  2021cites this paper
• Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis

  2021cites this paper
• Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation

  2021cites this paper
• Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung

  2021cites this paper
• Functional respiratory imaging in relation to classical outcome measures in cystic fibrosis: a cross-sectional study

  2021cites this paper
• Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy

  2021cites this paper
• Correlation of computed tomography findings and lung function in children and adolescents with cystic fibrosis

  2021cites this paper
• Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis.

  2021cites this paper
• Defect distribution index: A novel metric for functional lung MRI in cystic fibrosis

  2021cites this paper
• Ivacaftor partially corrects airway inflammation in a humanized G551D rat.

  2021cites this paper
• Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis

  2021cites this paper
• Reply to: Contrast Enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis.

  2021cites this paper
• Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis.

  2021cites this paper
• Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis

  2021cites this paper
• Cystic fibrosis

  2021cites this paper
• Retracing changes in cystic fibrosis understanding and management over the past twenty years.

  2021cites this paper
• Is Impulse Oscillometry System a Useful Method for the Evaluation and Follow-Up of Patients with Cystic Fibrosis?

  2021cites this paper
• Shedding light into the black box of infant multiple‐breath washout

  2020cites this paper
• Risk factors for progression of structural lung disease in school-age children with cystic fibrosis.

  2020cites this paper
• Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis

  2020cites this paper
• An adapted novel flow cytometry methodology to delineate types of cell death in airway epithelial cells

  2020cites this paper
• The Detection of Bile Acids in the Lungs of Paediatric Cystic Fibrosis Patients Is Associated with Altered Inflammatory Patterns

  2020cites this paper
• Treatment of pulmonary exacerbations in cystic fibrosis

  2020cites this paper
• The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease.

  2020cites this paper
• Longitudinal course of clinical lung clearance index in children with cystic fibrosis

  2020cites this paper
• Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial

  2020cites this paper
• Early Cystic Fibrosis Lung Disease

  2020cites this paper
• Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation

  2020cites this paper
• Novel imaging techniques for cystic fibrosis lung disease

  2020cites this paper
• BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis.

  2020cites this paper
• Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis.

  2020cites this paper
• The role of rhinovirus infections in young children with cystic fibrosis

  2020cites this paper
• Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review.

  2020cites this paper
• Assessment of early lung disease in young children with CF: A comparison between pressure‐controlled and free‐breathing chest computed tomography

  2020cites this paper
• Utility and validity of dynamic chest radiography in cystic fibrosis (dynamic CF): an observational, non-controlled, non-randomised, single-centre, prospective study

  2020cites this paper
• Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity

  2020cites this paper
• Rhinovirus Infection Drives Complex Host Airway Molecular Responses in Children With Cystic Fibrosis

  2020cites this paper
• Rhinovirus Infection Is Associated With Airway Epithelial Cell Necrosis and Inflammation via Interleukin-1 in Young Children With Cystic Fibrosis

  2020cites this paper
• Structural determinants of long-term functional outcomes in young children with cystic fibrosis

  2020cites this paper
• Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort

  2020cites this paper
• Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening

  2020cites this paper
• Structural lung abnormalities on computed tomography correlate with asthma inflammation in bronchoscopic alveolar lavage fluid

  2020cites this paper
• Molecular Heterogeneity in Cystic Fibrosis

  2020cites this paper
• The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease

  2020cites this paper
• Acute pulmonary exacerbation in cystic fibrosis

  2020cites this paper
• Airway Inflammation and Host Responses in the Era of CFTR Modulators

  2020cites this paper
• Pediatric Pulmonology

  2019cites this paper
• Acute Pulmonary Exacerbations in Cystic Fibrosis

  2019cites this paper
• Cystic Fibrosis: Pathophysiology of Lung Disease

  2019cites this paper
• Biofabrication of personalised anatomical models and tools for the clinic.

  2019cites this paper
• Single‐breath washout and association with structural lung disease in children with cystic fibrosis

  2019cites this paper
• Antioxidant supplementation for lung disease in cystic fibrosis.

  2019cites this paper
• Regional differences in infection and structural lung disease in infants and young children with cystic fibrosis.

  2019cites this paper
• What are the respiratory effects of e-cigarettes?

  2019cites this paper
• What are the respiratory effects of e-cigarettes?

  2019cites this paper
• Pediatric Pulmonology

  2019cites this paper
• CF derived scoring systems do not fully describe the range of structural changes seen on CT scans in PCD

  2019cites this paper
• The Evaluation of Lung Involvement in Patients with Cystic Fibrosis by Using Mediastinal Magnetic Resonance Imaging

  2019cites this paper